Within 10 years after robotic-assisted radical prostatectomy (RARP), a proportion of men were at increased risk of cardiovascular disease (CVD) and had substantial levels of fatigue, a new study found. Men post-RARP or on androgen deprivation therapy (ADT) were recruited into the study and asked to complete the Brief Fatigue Inventory (BFI), Stage of Change, and Scottish Physical Activity Questionnaires (SPAQ) over a 2-week period. Outcome measures were patient-reported fatigue, physical activity levels, and the 10-year risk of CVD (Q-Risk). Researchers found:

• 96 of 117 (82%) men approached consented to participate; 62 of 96 (65%) returned complete questionnaire data (RARP n=42, ADT n=20).
• All men reported fatigue with 21% post-RARP reporting clinically significant fatigue.
• Physical activity did not correlate with fatigue.
• Both groups on average were overweight and the post-RARP group had an 18.1% Q-Risk 2 score.